Skip to main content
CSL Ltd. logo

CSL Ltd. — Investor Relations & Filings

Ticker · CSL ISIN · AU000000CSL8 LEI · 529900ECSECK5ZDQTE14 ASX Manufacturing
Open in API
Filings indexed 2,555 across all filing types
Latest filing 2008-08-12 M&A Activity
Country AU Australia
Listing ASX CSL

About CSL Ltd.

https://www.csl.com/

CSL is a global biotechnology company that researches, develops, manufactures, and markets a diverse portfolio of medicines. The company operates through distinct business units. CSL Behring provides plasma-derived and recombinant biotherapies for patients with rare and serious diseases, including bleeding disorders, immunodeficiencies, and neurological disorders. CSL Seqirus is a leading provider of vaccines, with a focus on influenza prevention and public health. CSL Vifor specializes in therapies for iron deficiency and nephrology, addressing the full spectrum of kidney disease. Collectively, CSL delivers lifesaving and life-enhancing treatments to a global patient population.

Recent filings

Filing Released Lang Actions
CSL announces agreement to acquire Talecris 54 pages ?Kb
M&A Activity Classification · 95% confidence The document is an ASX announcement dated 13 August 2008 from CSL Limited regarding the agreement to acquire Talecris Biotherapeutics Holdings Corp. It details the acquisition terms, strategic rationale, financial highlights, regulatory review, funding, and integration plans. The document is an announcement of a merger/acquisition transaction, including financial and strategic details but not a full merger proxy statement or tender offer filing. It is not a full annual or interim report, nor a regulatory filing or earnings release. The content fits best under the category of M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids.
2008-08-12 English
Preliminary Final Report Accounts and Media Release 120 pages ?Kb
Annual Report Classification · 100% confidence The document is titled 'PRELIMINARY FINAL REPORT – ACCOUNTS AND MEDIA RELEASE' and includes detailed financial results for the full year ended 30 June 2008. It contains comprehensive financial data such as revenue, profit after tax, earnings per share, dividend information, and operational highlights. The document also includes a business review, outlook, and detailed segment sales information. The presence of a Directors' Report and Financial Report mentioned in the introduction further supports that this is a full annual financial report. The length of the document (15,000 characters) and the detailed financial and operational data confirm it is not merely an announcement or a summary. Therefore, this document fits the definition of an Annual Report (10-K equivalent).
2008-08-12 English
Change in substantial holding 36 pages ?Kb
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 604 Corporations Act 2001 Section 671B' and is a 'Notice of Change of Interests of Substantial Holder' addressed to CSL Limited. It details changes in voting power and relevant interests of a substantial shareholder (FMR Corp and FIL) over a period in early 2008, including dates, number of shares, and nature of transactions (market acquisition and disposition). This type of filing is a notification of changes in significant share ownership levels, which aligns with the definition of 'Major Shareholding Notification' (Code: MRQ). The document is lengthy and contains detailed transaction data, not just an announcement or a brief summary, confirming it is the actual notification. Therefore, the appropriate classification is MRQ with high confidence.
2008-07-23 English
AAH: Arana Therapeutics completes second project with CSL 2 pages ?Kb
Regulatory Filings Classification · 95% confidence The document is a press release announcing the completion of a second project with CSL by Arana Therapeutics. It discusses the successful engineering of a candidate antibody, triggering a payment under a collaboration agreement. The content focuses on business updates, partnership progress, and technology validation rather than financial results, regulatory filings, or detailed financial reports. The document length is 4255 characters, which is relatively short and reads like a corporate announcement rather than a detailed report. There is no indication of financial statements, audit information, management changes, or voting results. It is not a report publication announcement since it does not mention any report being attached or published. The document fits best under a general regulatory announcement or corporate update category. Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback for miscellaneous corporate announcements that do not fit other categories.
2008-06-04 English
Appendix 3B 7 pages ?Kb
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including the class and number of securities issued, terms, issue price, purpose, and quotation application to the ASX. It references specific ASX rules and includes warranties related to the quotation of securities. The content is consistent with a formal announcement of new share issuance and application for quotation rather than a full financial report or earnings release. The document length is about 10,587 characters, which is sufficient for a detailed announcement but does not contain financial statements or management discussion. Therefore, this document fits the category of a Share Issue/Capital Change announcement.
2008-04-13 English
CSL Half Year Report 2007-08 6 pages ?Kb
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Half Year Report 2007-2008' and contains detailed financial results for the half year ended December 2007, including sales, revenue, net profit, dividends, and EPS. It includes a Chairman's report, business group performance, business development, and outlook sections. The presence of comprehensive financial data and analysis for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document length is 7439 characters, which is sufficient to contain substantive financial data, not just an announcement or summary. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2008-04-07 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.